From: Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn's disease
ID | Sex | Age | Montreal | Previous relevant medications | BMI (Pr*/Po*) | CDAI (Pr/Po) | ESR (mm/h) (Pr/Po) | CRP (mg/L) (Pr/Po) | ALB (g/L) (Pr/Po) |
---|---|---|---|---|---|---|---|---|---|
01 | M | 16 | A1L3B1p | 5-ASA/IFX | 12.80/14.87 | 329.9/128.1 | 74/11 | 79.6/0.86 | 29.8/42.1 |
02 | F | 25 | A2L2B1 | Pred/5-ASA/IFX | 17.19/17.97 | 250.87/107.89 | 35/2 | 7.67/0.86 | 33.1/44.6 |
03 | F | 31 | A2L3B3p | 5-ASA/IFX | 16.41/18.75 | 257.44/118.24 | 23/18 | 7.38/0.86 | 35.3/38.3 |
04 | M | 23 | A2L1B2 | AZA/IFX | 16.98/17.63 | 249.37/129.2 | 3/2 | 1.2/1.58 | 48.8/50.5 |
05 | M | 15 | A1L1B1p | IFX | 14.80/17.36 | 293.71/144.47 | 8/4 | 32.47/2.01 | 32.1/39.6 |
06 | M | 51 | A3L3B3 | 5-ASA/IFX | 20.43/20.70 | 385.8/108.47 | 5/4 | 16.4/0.78 | 24.7/32.8 |
07 | M | 34 | A2L1B1 | AZA/IFX | 21.51/21.97 | 212.26/86.42 | 32.95/4 | 5.85/0.78 | 38.5/40.7 |